Grow Your Pharma Business Digitally
Virtual Booth
Contact Supplier
Product Reset all filters
01 1Welireg
Belzutifan
Merck & Co.
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 218
2022 Revenue in Millions : 123
Growth (%) : New Launch
Portfolio PDF
Product Web Link
Digital Content
Website
Corporate PDF